Curie Genetics is helmed by four medical oncologists and a genetic counsellor. Our oncologists have extensive years of experience in different cancer
types and have helped many patients recover from cancer. Their focus on the genetic and hereditary basis of cancer provides a holistic approach in
cancer management, leaving no stones unturned.


Ms Yanni Chen is an oncology genetic counsellor. She received her Master’s degree in Genetic Counselling from University of Sydney in 2016. Prior to Curie Oncology, Yanni was practicing at National Cancer Centre Singapore and has managed an array of patients diagnosed with hereditary cancer syndromes. Understanding the unique challenges faced by patients with hereditary cancer syndromes, she piloted a patient support programme for this group of patients. Yanni’s areas of interest are in hereditary cancer, cardiovascular and prenatal genetics.


Ms Tharisini is a genetic counsellor, well trained in an array of specialties such as cancer, paediatric genetics, cardiac/neurogenetics, and inborn error of metabolism (IEM). She received her Master’s Degree in Genetic Counselling from The National University of Malaysia (UKM) in 2020, and trained with clinical geneticists in Kuala Lumpur General Hospital and UKM Medical Centre. Besides, she was also actively involved in various seminars, conferences and support group meet-ups to gain valuable knowledge and insight on how people with genetic disorders live their life. Tharisini’s areas of interest are in Hereditary cancer, cardiovascular and prenatal genetics.


Ms Linda Tan is a clinical pharmacist. She received her Master of Pharmacy from University of Nottingham, UK in 2011. She did clinical practices at Worcestershire Acute Hospitals NHS Trust in the UK, National University Hospitalin Singapore and Mount Elizabeth Novena Hospital in Singapore. Prior to Curie Oncology, she had managed oncology patients by providing counselling of medications and chemotherapy at the oncology ward at Mount Elizabeth Novena Hospital. Linda’s areas of interest are in oncology, clinical pharmacy and pharmacogenetics.